期刊文献+

实现人源FGF-21高效可溶性表达的两种策略 被引量:4

Two strategies for efficient expression of soluble recombinant human FGF-21 protein
下载PDF
导出
摘要 采用分子伴侣协助蛋白表达的方法及乳糖自诱导的策略,实现人源FGF-21在大肠杆菌中的高效可溶性表达.结果显示,在分子伴侣Tig的协同表达下,融合蛋白TrxA-FGF-21可溶性达到92.4%.采用乳糖自诱导策略,融合蛋白TrxA-FGF-21表达量达到17.4%左右,菌体OD600达到12.4,可溶性TrxA-FGF-21相对产量是IPTG诱导发酵条件的5.5倍.该方法制备的重组FGF-21在C57BL/6小鼠体内具有降低血糖的生物学活性,甘油三酯水平与对照组相比也表现极显著差异(P<0.01). The expression of recombinant soluble FGF-21 protein was achieved through transferring another plasmid pTf16 which expressed molecular chaperone Tig.On the other hand,the yield of FGF-21 was greatly improved with the method of lactose auto-induction.The result showed that the soluble TrxA-FGF-21 fusion protein reached 92.4% by molecular chaperone co-expression.With lactose auto-induction,the expression quantity of fusion protein was 17.4% of the total proteins,and the OD600 was 12.4;thus relative yield was 5.5 times higher than IPTG induction.The biological activities of recombinant FGF-21 were studied in vivo in healthy C57BL/6 mice.It showed that recombinant FGF-21 can lower blood glucose obviously in mice(P 0.05 or P 0.01).The recombinant FGF-21 treatment also led to a significant decrease in concentration of triglyceride in C57BL/6 mice(P 0.01).
出处 《华东师范大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第6期114-121,共8页 Journal of East China Normal University(Natural Science)
关键词 成纤维生长因子21 分子伴侣 乳糖自诱导 fibroblast growth factor 21 molecular chaperone lactose auto-induction
  • 相关文献

参考文献14

  • 1NISHIMURA T, NAKATAKE Y, KONISHI M, et al. Identification of a nove FGF, FGF 21, preferentially ex pressed in the liver[J]. Biochim Biophys Acta, 2000, 1492(1): 203- 206.
  • 2IZUMIYA Y, BINA H A, OUCHI N, et al. FGF-21 is an Akt-regulated myokine[J]. FEBS Lett, 2008, 582 (17) : 3805-3810.
  • 3KHARTONENKOV A, SHIYANOVA T L, KOESTER A, et al. FGF-21 as a novel metabolic regulator[J]. J Clin Invest, 2005, 115(6) : 1627-1635.
  • 4WENTE W, EFANOV A M, BRENNER M, et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways[J]. Dia- betes, 2006, 55(9) : 2470-2478.
  • 5COSKUN T, BINA H A, SCHNEIDER M A, et al. Fibroblast growth factor 21 corrects obesity in mice[J]. En- docrinology, 2008, 149(12) : 6018-6027.
  • 6姜媛媛,尹成凯,李晋南,任桂萍,张薇,李德山.利用SUMO融合系统高效表达可溶性重组蛋白的研究[J].东北农业大学学报,2008,39(10):57-62. 被引量:22
  • 7崔硕硕,张镱,林学政,沈继红.分子伴侣共表达对低温脂肪酶Lip-837异源可溶性表达的影响[J].海洋科学进展,2011,29(1):105-112. 被引量:7
  • 8ARAYO H, KAZUNORI H, NOBUTADA T, et al. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic eells[J]. Protein Expression and Purification, 2008, 59(1): 9-17.
  • 9顾娟,劳勋,金明飞,黄静,吴自荣.人胰高血糖素样肽-1突变体融合蛋白在大肠杆菌中的自诱导表达优化[J].微生物学通报,2010,37(5):726-731. 被引量:8
  • 10冯杉.T7表达系统及自诱导蛋白产出策略[J].北京教育学院学报(自然科学版),2009,4(3):10-15. 被引量:8

二级参考文献84

  • 1刘爽,胡宝成.原核系统可溶性表达策略[J].生物技术通讯,2005,16(2):172-175. 被引量:35
  • 2林学政,杨秀霞,边际,黄晓航.南大洋深海嗜冷菌2-5-10-1及其低温脂肪酶的研究[J].海洋学报,2005,27(3):154-158. 被引量:21
  • 3Baneyx F. Recombinant protein expression in Escherichia coli[J]. Curr Opin Biotechnol, 1999(10): 411-421.
  • 4Makrides S C. Strategies for achieving high-level expression of genes in Escherichia coli[J]. Micobiol Rev, 1996, 60: 512-538.
  • 5Marblestone J G, Edavettal S C, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO[J]. Protein Science, 2006, 15: 182-189.
  • 6Butt T R, Edavettal S C, Hall J P, et al. SUMO fusion technology for diffficult-to-express proteins[J]. Protein Expr Purif, 2005, 43 (1): 1-9.
  • 7Malakhov M P, Mattern M R, Malakhov O A, et al. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins[J]. Struct Funct C, en, 2004(5): 75-86.
  • 8Sambrook J. Fritsch E F, Maniatis T. Mogecular cloning, a laboratory manual[M]. 2nd ed. New York: Cold Spring Harbor Laboratary Press, 1989: 880-898.
  • 9Ausubel F M, Brent R, Kingston R E, et al. Short protocols in molecular biology[M]. 3rd ed. Boston: John Wiley & Sons, Inc, 1992: 652-658.
  • 10Wente W, Efanov A M, Brenner M, et al. Fibroblast growth factor- 21 improves oancreatic-cell function and survival by activation of extracellular sigual-regulated kinase 1/2 and akt signaling pathways[J]. Diabetes, 2006, 55: 2470-2478.

共引文献75

同被引文献56

  • 1井明艳,孙建义.蛋白质的折叠调控与包涵体的形成[J].浙江大学学报(农业与生命科学版),2004,30(6):690-696. 被引量:25
  • 2高飞,范清林,邹文艺,宋礼华.包涵体蛋白的层析复性技术研究进展[J].生物技术通报,2006,22(2):56-59. 被引量:2
  • 3徐玉凤,周功克,周露,李一勤,刘进元.水稻金属硫蛋白基因家族成员对铅胁迫的应答及其在铅敏感酵母中的功能互补[J].科学通报,2007,52(12):1419-1424. 被引量:3
  • 4Kharitonenkov A,Shiyanova TL,Koester A,et al.FGF-21 as a novel metabolic regulator.J ClinInvest,2005,115(6):1627-1635.
  • 5Kharitonenkov A,Wroblewski VJ,Koester A,et al.The metabolic state of diabetic monkeys isregulated by fibroblast growth factor-21.Endocrinology,2007,148(2):774-781.
  • 6Coskun T,Bina HA,Schneider MA,et al.Fibroblast growth factor-21 corrects obesity inmice.Endocrinology,2008,149(12):6018-6027.
  • 7Vera A,Gonzalez-Montalban N,Aris A,et al.Theconformational quality of insoluble recombinantproteins is enhanced at low growth temperatures.Biotechnol Bioeng,2007,96(6):1101-1106.
  • 8Li JFj Zhang J,Zhang Z,et al.Production ofbioactive human beta-defensin-4 in Escherichiacoli using SUMO fusion partner.Protein J,2010,29(5):314-319.
  • 9Satakami M,Curtis R.Production of recombinantpeptides as fusions with SUMO.Protein Expr Purif,2011,78(2):113-119.
  • 10Marblestone JG,Edavettal SC,Lim Y,et al.Comparison of SUMO fusion technology withtraditional gene fusion systems:enhancedexpression and solubility with SUMO.Protein Sci,2006,15(1):182-189.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部